William Fang
Strategy Lead 于 BIO Protocol
William Fang 目前是 BIO Protocol 的战略负责人。此前他曾在 Sora Ventures 和 Goldman Sachs 工作。他毕业于 Tsinghua University。
新闻提及
For a decade, AI, Web3, and Bio have scaled as parallel frontiers, but that era is ending.The defining companies of the
For a decade, AI, Blockchain, and Bio have scaled as parallel frontiers - but that era is ending.The defining companies
We're excited to announce The Convergence, YZi Labs' flagship conference of the year. On May 12 at the iconic Computer H
The scientist who would have studied your disease probably chose a different problem.
Most people describe biotech companies as a jump from discovery to application.
Prompt-to-DeFi Strategist Challenge: BNB Chain Edition
Bio Monthly (March 2026): AI Scientist Swarms, Virtual Biotech Lab, Peptide Drug Discovery
5 DeFi Strategies Built With a Text Prompt on BNB Chain
A virtual lab ran for 8 hours.
A virtual lab ran for 8 hours yesterday.